Điều trị chống đông sau can thiệp động mạch vành qua da với sự cấy ghép stent ở bệnh nhân không có và có chỉ định điều trị chống đông đường uống

Silber S, Albertsson P, Avilés FF et al. (2005) Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 26: 804–847 Task Force for Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of European Society of Cardiology, Bassand JP, Hamm CW, Ardissino D et al. (2007) Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart 28: 1598–1660 Mehta SR, Yusuf S, Peters RJ et al. (2001) Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 358: 527–333 Silber S, Borggrefe M, Boehm M et al. (2007) Positionspapier der DGK zur Wirksamkeit und Sicherheit von Medikamente freisetzenden Koronarstents (DES) – Eine evidenzbasierte Analyse von 71 randomisierten Studien mit 28.984 Patienten. Kardiologe 1: 84–111 Fuster V, Rydén LE, Cannom DS et al. (2006) ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). Eur Heart J 27: 1979–2030 Dentali F, Douketis JD, Lim W, Crowther M (2007) Combined aspirin-oral anticoagulant therapy compared with oral anticoagulant therapy alone among patients at risk for cardiovascular disease. A meta-analysis of randomized trials. Arch Intern Med 167: 117–124 Johnson S, Rogers K, Delate T, Witt D (2008) Outcomes associated with combined antiplatelet and anticoagulant therapy. Chest (Epub ahead of print) Schühlen H, Hadamitzky M, Walter H et al. (1997) Major benefits from antiplatelet therapy for patients at high risk for adverse cardiac events after coronary Palmaz– Schatz stent placement. Circulation 95: 2015–2021 Urban P, Macaya C, Rupprecht HJ et al. (1998) Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients. Circulation 98: 2126–2132 The ACTIVE Writing Group on behalf of the ACTIVE Investigators (2006) Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial. Lancet 367: 1903–1912 Lip GYH, Karpha M (2006) Anticoagulant and antiplatelet therapy use in patients with atrial fibrillation undergoing percutaneous coronary intervention: the need for consensus and a management guideline. Chest 130: 1823–1827 Rubboli A, Colletta M, Sangiorgio P, Di Pasquale G (2004) Antithrombotic strategies in patients with an indication for long-term anticoagulation undergoing coronary artery stenting: safety and efficacy data from a single center. Ital Heart J 5: 919–925 Orford JL, Fasseas P, Melby S et al. (2004) Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation. Am Heart J 147: 463–467 Mattichack SJ, Reed PS, Gallagher MJ et al. (2005) Evaluation of safety of warfarin in combination with antiplatelet therapy for patients treated with coronary stents for acute myocardial infarction. J Interven Cardiol 18: 163–166 Khurram Z, Chou E, Minutello R et al. (2006) Combination therapy with aspirin, clopidogrel and warfarin following coronary stenting is associated with a significant risk of bleeding. J Invasive Cardiol 18: 162–164 Porter A, Konstantino Y, Iakobishvili Z et al. (2006) Short-term triple therapy with aspirin, warfarin, and a thienopyridine among patients undergoing percutaneous coronary intervention. Catheter Cardiovasc Interv 68: 56–61 Karjalainen PP, Porela P, Ylitalo A et al. (2007) Safety and efficacy of combined antiplatelet-warfarin therapy after coronary stenting. Eur Heart J 28: 726–732 DeEugenio D, Kolman L, DeCaro M et al. (2007) Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy. Pharmacotherapy 27: 691–696 Rubboli A, Colletta M, Herzfeld J et al. (2007) Peri-procedural and medium-term antithrombotic strategies in patients with an indication for long-term anticoagulation undergoing coronary angiography and intervention. Coron Artery Dis 18: 193–199 Nguyen MC, Lim YL, Walton A et al. (2007) Combining warfarin and antiplatelet therapy after coronary stenting in the Global Registry of Acute Coronary Events: is it safe and effective to use just one antiplatelet agent? Eur Heart J 28: 1717–1722 Arab D, Lewis B, Cho L et al. (2005) Antiplatelet therapy in anticoagulated patients requiring coronary intervention. J Invasive Cardiol 17: 549–554 Helft G, Gilard M, Le Feuvre C, Zaman AG (2006) Drug insight: antithrombotic therapy after percutaneous coronary intervention in patients with an indication for oral anticoagulation. Nat Clin Pract Cardiovasc Med 3: 673–680 Vahanian A, Baumgartner H, Bax J et al. (2007) Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 28: 1267 De Caterina R, Husted S, Wallentin L et al. (2007) Anticoagulants in heart disease: current status and perspectives. Eur Heart J 28: 880–913 Rubboli A, Verheugt FW (2007) Antithrombotic treatment for patients on oral anticoagulation undergoing coronary stenting. A review of the available evidence and practical suggestions for the clinician. Int J Cardiol 2007 (Epub ahead of print) Huber K, Baumgartner H, Darius H et al. (2006) Der Einsatz von Clopidogrel bei Patienten mit akuten Koronarsyndromen, nach perkutaner koronarer Intervention und Stentimplantation. J Kardiol 13: 168–174